Skip to content

Brief, Scaleable Intervention for Coronavirus (COVID-19) Mental Health Sequelae in College Students

Pilot Study of a Brief, Scaleable Intervention for COVID-19 Mental Health Sequelae in College Students

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04558411
Enrollment
153
Registered
2020-09-22
Start date
2020-09-12
Completion date
2020-12-15
Last updated
2021-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Affect, Emotional Regulation

Brief summary

The major aim of this pilot study is to evaluate a brief coping skills intervention for college students, based on an evidence-based treatment and delivered remotely via 14 short daily videos. Participants will be 150 Rutgers undergraduates who are enrolled in Fall 2020. Participants in the experimental group (n=100) will receive 4 daily smartphone surveys assessing stress, affect, and other related factors for two weeks before, during, and after the 2-week coping skills intervention. Participants in the control group (n=50) will receive assessments over the same time period with no skills intervention. Both groups will be assessed weekly throughout the Fall semester to monitor the transition to the new semester and longer-term impact of the intervention. The control condition participants will have access to the skills videos at the end of the study.

Interventions

BEHAVIORALDialectical Behavioral Therapy (DBT) Skills

14 brief videos that teach DBT skills.

Sponsors

Rutgers, The State University of New Jersey
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 18 years or older * Matriculated at Rutgers during Fall of 2020 (on campus and/or remote) * Currently residing in the United States * Willingness to follow study requirements, as evidenced by an ability to provide written informed consent and read, understand, and complete the study procedures * iOS and Android smartphone compatible with MetricWire

Exclusion criteria

* Non-English speaking * Unable to understand or provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
DistressSix week daily monitoring periodDistress, as assessed via smartphone Ecological Momentary Assessment (EMA), 0 through 10 scale, 10 equals more distress.
Emotion regulationSix week daily monitoring periodAssessed with the Difficulties in Emotion Regulation Scale (DERS); scores range from 36-180, higher scores equal more distress
Distress (within-person change)Six week daily monitoring periodAssessed via EMA in the experimental group, 0 through 10 scale, 10 equals more distress.

Secondary

MeasureTime frameDescription
Maintenance of improvement in emotion regulationSix week post-daily monitoring periodAssessed with the Difficulties in Emotion Regulation Scale (DERS), scores range from 36-180, higher scores equal more distress

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026